InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
43%
T+90 mean return
-8.1%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Bishop Hans Edgar, Director. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. In total, 24 reports have been recorded. Activity tracked since 23 February 2022. The latest transaction was filed on 6 July 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations24 total
6,297 shares0Common StockSEC:0001480212-26-000008:0
5,628 shares0Common StockSEC:0001480212-25-000006:0
7,842 shares0Common StockSEC:0001562180-25-005349:0
16,339 shares0Common StockSEC:0001562180-25-003066:0
14,285 shares0Common StockSEC:0001562180-25-000238:0
5,938 shares0Common StockSEC:0001562180-24-007283:0
4,911 shares0Common StockSEC:0001562180-24-005643:0
2,774 shares0Common StockSEC:0001562180-24-003354:0
1,678 shares@ US$147.4829.7% of flowCommon StockSEC:0001127602-24-010679:0
750 shares@ US$147.4813.3% of flowCommon StockSEC:0001127602-24-010679:1
4,901 shares0Common StockSEC:0001562180-24-000342:0
6,925 shares0Common StockSEC:0001562180-23-007236:0
4,152 shares0Common StockSEC:0001562180-23-005765:0
7,716 shares0Common StockSEC:0001562180-23-003474:0
1,658 shares@ US$136.8228.0% of flowCommon StockSEC:0000899243-23-009220:0
6,702 shares0Common StockSEC:0001562180-23-000267:0
4,012 shares0Common StockSEC:0001562180-22-007109:0
145,380 shares@ US$0.1014.2% of flowCommon StockSEC:0001209191-22-049299:0
3,328 shares0Common StockSEC:0001562180-22-005623:0
2,880 shares0Common StockSEC:0001562180-22-003313:0
1,785 shares@ US$136.820.0007% mcap100.0% of flowCommon StockSEC:0001127602-22-010045:0
993,428 shares@ US$0.100.013% mcap100.0% of flowCommon StockSEC:0001209191-22-013118:0
546,806 sharesCommon StockSEC:0001209191-21-042796:0
546,806 sharesCommon StockSEC:0001209191-21-042796
24 of 24 declarations
About Bishop Hans Edgar
Hans Edgar Bishop is a Director at Lyell Immunopharma, Inc., Agilent Technologies, Inc., and Sana Biotechnology, Inc. He contributes to the governance of the companies by participating in strategic decisions. His experience is valuable in guiding these firms towards their objectives.
